DMD
Clinical trials for DMD explained in plain language.
Never miss a new study
Get alerted when new DMD trials appear
Sign up with your email to follow new studies for DMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy hope for boys with duchenne muscular dystrophy
Disease control Recruiting nowThis early-stage study tests a new gene therapy called BBM-D101 in 9 boys aged 4 to 8 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help restore a missing muscle protein. Participants receive one infusion and are monitored for side effects and changes…
Matched conditions: DMD
Phase: PHASE1, PHASE2 • Sponsor: Belief BioMed (Beijing) Co., Ltd • Aim: Disease control
Last updated May 17, 2026 23:54 UTC
-
New pill aims to strengthen muscles in boys with duchenne
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in about 51 boys aged 7 to 10 with Duchenne muscular dystrophy (DMD). The goal is to find the best dose and see if it is safe and helps muscle strength. Participants will take the drug or a placebo for 12 weeks, and all will continue …
Matched conditions: DMD
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug aims to restore muscle protein in boys with DMD
Disease control Recruiting nowThis study tests a weekly intravenous drug, NS-089/NCNP-02, in 20 boys aged 4 to 14 with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The goal is to help their bodies produce a missing muscle protein, dystrophin, to slow muscle damage. Participants must…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Swiss database tracks muscle disease patients to boost future treatments
Knowledge-focused Recruiting nowThis study is a registry that collects health information from children and adults in Switzerland who have neuromuscular disorders like SMA, Duchenne, and Becker muscular dystrophy. It does not test a new treatment but gathers data on symptoms, treatments, and quality of life ove…
Matched conditions: DMD
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC